Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Eur J Med Res ; 27(1): 63, 2022 May 03.
Article in English | MEDLINE | ID: mdl-35505368

ABSTRACT

BACKGROUND: Immune thrombocytopenia (ITP) is a rare autoimmune disorder characterized by low platelet counts and increased bleeding risk. The disease may be induced by other disorders, including malignancies, autoimmune diseases, infectious agents or drugs. However, ITP has also been described following vaccinations, such as the measles-mumps-rubella vaccination. In rare cases, ITP may occur in children who received a DTaP-IP (diphtheria, tetanus, acellular pertussis vaccine and inactivated poliovirus) vaccine. Hereinafter, we report the first well-documented cases of ITP in an adult patient in the temporal context of a DTaP-IP vaccination. CASE PRESENTATION: This case report attempts to capture the life-threatening picture of a 36-year-old otherwise healthy Caucasian woman with newly diagnosed severe immune thrombocytopenia in the temporal context of a DTaP-IP vaccination. Four days after receiving the vaccine, the women presented to her primary care physician with malaise, fever and recurrent epistaxis. Clinical examination revealed oral petechiae, ecchymoses, and non-palpable petechiae on both legs. The patient was immediately referred to a local hematology unit where she developed hematuria and an intestinal bleeding (WHO Bleeding Grade III) requiring multiple transfusions. After receiving oral corticosteroids and intravenous immunoglobulins, her platelets gradually recovered. Common causes of secondary ITP were ruled out by laboratory investigations, bone marrow and peripheral blood examinations. This raises the possibility of a (secondary) vaccination-associated thrombocytopenia. To the best of our knowledge, this is the first well-documented case of a DTaP-IP vaccination-related ITP in an adult patient in the English literature. CONCLUSION: Although a causal connection between both entities may not be established, we would like to raise awareness in clinicians that ITP following DTaP-IP vaccinations is potentially not limited to children, but may also occur in adults. Users of DTaP-IP booster vaccines should be alert of the possibility of such adverse reactions.


Subject(s)
Diphtheria-Tetanus-acellular Pertussis Vaccines , Diphtheria , Poliomyelitis , Purpura, Thrombocytopenic, Idiopathic , Tetanus , Thrombocytopenia , Whooping Cough , Adult , Antibodies, Bacterial , Child , Diphtheria/etiology , Diphtheria/prevention & control , Diphtheria-Tetanus-acellular Pertussis Vaccines/adverse effects , Female , Humans , Immunization, Secondary/adverse effects , Poliomyelitis/chemically induced , Poliomyelitis/prevention & control , Poliovirus Vaccine, Inactivated/adverse effects , Purpura, Thrombocytopenic, Idiopathic/chemically induced , Tetanus/etiology , Tetanus/prevention & control , Vaccination/adverse effects , Whooping Cough/etiology , Whooping Cough/prevention & control
2.
Nutr Health ; 25(4): 281-290, 2019 Dec.
Article in English | MEDLINE | ID: mdl-31500515

ABSTRACT

BACKGROUND: Lifestyle interventions, including dietary modifications, play a key role in the treatment of type 2 diabetes. By the second half of the last century, dietary oatmeal interventions had frequently been used in patients with diabetes; however, with the widespread introduction of insulin, this practice gradually fell into disuse. Within the last decades, the original oatmeal intervention, first described in 1903, has been modified towards a hypocaloric, low-fat, and plant-based intervention. AIM: The aim of this review was to investigate the current role of these adapted short-term dietary oatmeal interventions in the treatment of patients suffering from poorly-controlled type 2 diabetes. A special focus was put on opportunities for and barriers to its clinical implementation and its potential mechanisms of action. METHODS: The electronic databases of PubMed and Google Scholar were searched using the keywords "oat," "oats," "oatmeal," and "diabetes." RESULTS: While there are a limited number of clinical studies including hypocaloric short-term dietary oatmeal interventions, there is evidence that these interventions may lead to a significant decrease in mean blood glucose levels and a significant reduction of insulin dosage in patients suffering from poorly-controlled type 2 diabetes. CONCLUSION: Modified short-term dietary oatmeal interventions are an effective and economical tool in the treatment of patients suffering from poorly-controlled type 2 diabetes.


Subject(s)
Avena , Diabetes Mellitus, Type 2/blood , Diabetes Mellitus, Type 2/diet therapy , Diet/history , Dietary Fiber/therapeutic use , Edible Grain , beta-Glucans/metabolism , Blood Glucose/metabolism , Caloric Restriction , History, 20th Century , Humans , Insulin/administration & dosage , Life Style
SELECTION OF CITATIONS
SEARCH DETAIL
...